HPV (Types 16 & 18) Vaccine Market to Reach USD 8.2 Billion by 2030
According to a newly published market research report by 24LifeSciences, global Human Papillomavirus Vaccine (Types 16, 18) market was valued at USD 4.5 billion in 2023 and is projected to reach USD 8.2 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20242030. Human Papillomavirus (HPV) vaccines targeting types 16 and 18 are prophylactic...
0 Commenti 0 condivisioni 18 Views 0 Anteprima
Sponsorizzato
Sponsorizzato
Sponsorizzato